EP1781391B1 - Bicomponent fiber wick - Google Patents
Bicomponent fiber wick Download PDFInfo
- Publication number
- EP1781391B1 EP1781391B1 EP04716122A EP04716122A EP1781391B1 EP 1781391 B1 EP1781391 B1 EP 1781391B1 EP 04716122 A EP04716122 A EP 04716122A EP 04716122 A EP04716122 A EP 04716122A EP 1781391 B1 EP1781391 B1 EP 1781391B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fiber
- bicomponent
- fibers
- fluid
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 240
- 229920002647 polyamide Polymers 0.000 claims abstract description 73
- 239000004952 Polyamide Substances 0.000 claims abstract description 72
- 239000012530 fluid Substances 0.000 claims abstract description 57
- 239000000463 material Substances 0.000 claims abstract description 48
- 239000012491 analyte Substances 0.000 claims abstract description 17
- 238000012545 processing Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 22
- -1 polyethylene terephthalate Polymers 0.000 claims description 19
- 229920002292 Nylon 6 Polymers 0.000 claims description 7
- 239000004743 Polypropylene Substances 0.000 claims description 7
- 229920001155 polypropylene Polymers 0.000 claims description 7
- 229920002302 Nylon 6,6 Polymers 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 4
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 3
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 claims description 2
- 229920000571 Nylon 11 Polymers 0.000 claims description 2
- 229920000299 Nylon 12 Polymers 0.000 claims description 2
- 229920001007 Nylon 4 Polymers 0.000 claims description 2
- 229920000305 Nylon 6,10 Polymers 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims 1
- 239000000306 component Substances 0.000 description 67
- 239000011162 core material Substances 0.000 description 25
- 238000002788 crimping Methods 0.000 description 17
- 238000003556 assay Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 229920001778 nylon Polymers 0.000 description 12
- 239000000654 additive Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 239000004677 Nylon Substances 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000002861 polymer material Substances 0.000 description 6
- 239000008358 core component Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 239000012429 reaction media Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 229920000098 polyolefin Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000009987 spinning Methods 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002074 melt spinning Methods 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 description 1
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 description 1
- KZFBHCCLJSAHBQ-UHFFFAOYSA-N Benzoylecgonine Natural products CN1C2CCC1C(C(C2)OC(=C)c3ccccc3)C(=O)O KZFBHCCLJSAHBQ-UHFFFAOYSA-N 0.000 description 1
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 1
- 101000632994 Homo sapiens Somatostatin Proteins 0.000 description 1
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 description 1
- 102000034755 Sex Hormone-Binding Globulin Human genes 0.000 description 1
- 102100029563 Somatostatin Human genes 0.000 description 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
- 102000014034 Transcortin Human genes 0.000 description 1
- 108010011095 Transcortin Proteins 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 229920006097 Ultramide® Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229950006073 cotinine Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 229920006240 drawn fiber Polymers 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- GVGYEFKIHJTNQZ-RFQIPJPRSA-N ecgonine benzoate Chemical compound O([C@@H]1[C@@H]([C@H]2CC[C@@H](C1)N2C)C(O)=O)C(=O)C1=CC=CC=C1 GVGYEFKIHJTNQZ-RFQIPJPRSA-N 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229960001078 lithium Drugs 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- KQPKPCNLIDLUMF-UHFFFAOYSA-N secobarbital Chemical compound CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O KQPKPCNLIDLUMF-UHFFFAOYSA-N 0.000 description 1
- 229960002060 secobarbital Drugs 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000002166 wet spinning Methods 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/12—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyamide as constituent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
Definitions
- the invention relates generally to hygroscopic wicks and, more particularly, to bicomponent fiber wicks that may be adapted for transmitting analyte fluids in assay devices.
- test devices for use in the home, office, clinic, hospital or doctor's surgery for providing an analytical result which is rapid and which requires a minimal degree of skill and involvement by the user. Examples of this are the test devices or assays for pregnancy and fertile period (ovulation). Typically in such devices the number of operations in getting the results should be minimized.
- Typical assay devices comprise a housing, a reaction medium positioned in the housing, upon which the assay chemistry occurs, and a wick for collecting the liquid to be assayed and transferring it to the reaction medium.
- the assay device should merely require that a collection portion of the device be contacted with a sample (e.g., a urine sample for pregnancy testing), and thereafter no further user actions are required.
- the sample is carried from the collection portion to the reaction medium via the wick.
- Observation of changes to the reaction medium or a substrate carrying the reaction medium provide an analytical result.
- the analytical result should be observable within a matter of minutes following sampling.
- the actual analytic techniques used to obtain the results typically determine the presence or absence of and/or quantify the amount of various analytes in tissues and fluids of organisms.
- Currently most diagnostic testing is done with blood, urine, fecal material, saliva, or tissue biopsy. Testing based on these materials, however, entails substantial invasion of privacy and poses a significant safety hazard (particularly with the testing of blood).
- Improved assay devices are required that allow for greater speed and control of the transport and analysis of the fluid sample. These devices will depend on improved wick materials and structures.
- the present invention provides wicks that make use of bicomponent fibers in which at least one of the fiber components a polyamide material.
- An illustrative aspect of the invention provides a bicomponent fiber wick for use in processing an analyte fluid.
- the bicomponent fiber wick comprises a self-sustaining, fluid transmissive body comprising a plurality of bundled, crimped, continious bicomponent fibers bonded to each other at spaced apart contact points.
- Each bicomponent fiber has a fiber structure comprising a first fiber component formed from a polyamide material and a second fiber component.
- the fibers collectively define tortuous fluid flow paths through the fluid transmissive body, the fiber structure being configured for controlling flow of the analyte fluid through the fluid transmissive body with at least a portion of the first fiber component in contact with the analyte fluid.
- Figure 1 is a flow diagram of a process for manufacturing a bicomponent fiber wick according to an embodiment of the invention:
- Figure 2 is a cross-sectional view of a sheath-core bicomponent fiber that may be used in embodiments of the invention.
- Figure 3 is a nOL-to-scale perspective view of a bicomponent fiber wick according to an embodiment of the invention.
- the present invention provides bicomponent fiber wicks that are particularly adapted for use in devices requiring rapid, controlled transport of fluids. They are particularly adaptable for use in assay devices requiring transport of analyte fluids.
- analyte fluid means a fluid sample that is to be analyzed for the presence of one or more analytes in the fluid sample and/or to quantify the amount of one or more analytes present in the fluid sample.
- the wicks of the present invention are formed from bicomponent fibers the structure and material constituents of which may be tailored to provide specific fluid transport properties for particular analytes and analyte fluids.
- Bicomponent fibers have been used to some extent in wicks and medical assay devices.
- Most prior art assay devices are constructed from low cost mono-component fibers formed from such materials as low density polyethylene (LDPE), polypropylene(PP) high density polyethylene (HDPE), ultra-high molecular weight polyethylene (UHMW), polypropylene (PP), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), polyester, and polyethersulfone (PES).
- LDPE low density polyethylene
- PP high density polyethylene
- UHMW ultra-high molecular weight polyethylene
- PP polypropylene
- PVDF polyvinylidene fluoride
- PTFE polytetrafluoroethylene
- polyester and polyethersulfone
- nylon processing often requires additional procedures to avoid inadvertent moisture absorption by the nylon fibers. In some instances, this may require a dedicated drying process.
- spun nylon fibers are subject to changes over time (aging effects).
- the more typical, less expensive polymers such as polyolefins and polyesters that are presently used to form assay device wicks have two disadvantages: (1) They often require an additional material such as a surfactant in order to provide adequate fluid transfer performance; and (2) unless functionalized, derivatized or modified, they do not provide a reactive platform for other additives.
- the wick embodiments of the present invention make use of bicomponent fibers with natural hydrophilic properties due to the use of polyamide materials in the fiber structure. The structure of these fibers are adapted to provide an optimum polyamide material amount while maintaining the desired flow characteristics for the final wick product.
- bicomponent fibers in hydrophilic structures, generally, is well known in the art.
- U.S. Pat. No. 5,607,766 issued Mar. 4, 1997 U.S. Pat. No. 5,620,641 issued Apr. 15, 1997
- U.S. Pat. No. 5,633,082 issued May 27, 1997 disclose the manufacture and use of bicomponent fibers comprising a core of a thermoplastic material covered by a sheath of polyethylene terephthalate.
- These patents note that such fibers are particularly useful in the production of elongated, highly porous elements such as in the wicks used to transport bodily fluids to a test site in a diagnostic device.
- US-A-2002/0193030 and EP-A-0171807 are disclosing bicomponent fiber wicks having a polyamide-based component.
- the wick embodiments of the present invention are self-sustaining structures formed from such fibers.
- the term "bicomponent” as used herein refers to the use of two polymers of different chemical nature placed in discrete cross-sectional areas of a fiber structure. The two polymers are arranged in substantially constantly positioned distinct zones across the cross-section of the bicomponent fibers that extend continuously along the length of the bicomponent fibers. While other forms of bicomponent fibers are possible, the more common bicomponent fiber types are of the "side-by-side” and "sheath-core” types. The first type is so-named because the two polymer materials literally form a side-by-side cross-sectional configuration. In “sheath-core" bicomponent fibers, a sheath of one polymer material is spun to completely cover and encompass a core of another polymer material, typically a low shrinkage, high strength thermoplastic polymeric material.
- the wick structures of the present invention may be formed from either side-by-side or sheath-core bicomponent fibers that include at least one polyamide fiber component.
- the polyamide fiber component may be selected from the group consisting of nylon 6, nylon 6,6, nylon 4, nylon 610, nylon 11, and nylon 12, or copolymers of any of the various nylons with hydrophilic moieties, such as polyethylene glycol and/or poly(ethylene oxide) diamines.
- both bicomponent fiber components may be polyamides selected from the group listed above.
- the polymer or polymers of the second fiber component may depend on the bicomponent fiber type.
- a first fiber component may be formed from a polyamide material and a second fiber component may be formed from a material selected from a group including but not limited to polyolefins, polyesters, polyamides, polysulfones, etc.
- the sheath component may be formed from a polyamide material while the core component may be formed from a thermoplastic polymer material selected from a group including but not limited to polyamides (such as nylon 6, nylon 6,6 and other nylons) polyesters (such as polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate and polylactic acid) and polyolefins (such as syndiotactic, isotactic polypropylene and polyethylene).
- polyamides such as nylon 6, nylon 6,6 and other nylons
- polyesters such as polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate and polylactic acid
- polyolefins such as syndiotactic, isotactic polypropylene and polyethylene
- both side-by-side and sheath-core bicomponent fiber types may have a first component of one polyamide material and a second component of a another polyamide material.
- wick embodiments of the invention could, for example, be formed from sheath-core fibers having a core component of nylon 6 and a sheath component of nylon 6,6.
- fiber material content and the fiber structure of both sheath-core and side-by-side fiber types has a significant impact on certain properties of the final wick product. It has also been found that fiber material content and fiber structure may be selected to provide desired wick properties and, in fact, may be optimized based on various design criteria.
- the bicomponent fibers used in embodiments of the invention may be produced by a number of common techniques.
- Such techniques are conventional melt spinning processes in which molten polymer is pumped under pressure to a spinning head and extruded from spinneret orifices into a multiplicity of continuous fibers.
- Melt spinning is only available for polymers having a melting point temperature less than its decomposition temperature, such as nylon, polypropylene and the like, whereby the polymer material can be melted and extruded to fiber form without decomposing.
- Other polymers, such as acrylics cannot be melted without blackening and decomposing.
- Such polymers can be dissolved in a suitable solvent (e.g., acetate in acetone) of typically 20% polymer and 80% solvent.
- the solution is pumped at room temperature through the spinneret, which is submerged in a bath of liquid (e.g., water) in which the solvent is soluble to solidify the polymeric fibers. It is also possible to dry spin the fibers into hot air, rather than a liquid bath, to evaporate the solvent and form a skin on the fiber surface. Other common spinning techniques may also be used.
- liquid e.g., water
- Other common spinning techniques may also be used.
- the fibers are commonly attenuated by withdrawing them from the spinning device at a speed faster than the extrusion speed.
- the fibers may be attenuated by taking them up on nip rolls rotating at a speed faster than the rate of extrusion or between nip rolls operating at different speeds. Depending on the nature of the polymer, drawing the fibers in this manner can make them stronger by making them more crystalline.
- Attenuation can also be effected through the use of a melt blowing process.
- the fibers are attenuated by contacting them with a fluid such as high velocity air as they emanate from the spinneret orifices.
- the effect of the fluid is to draw the fibers into fine filaments.
- These filaments may be collected as an entangled web of fibers on a continuously moving surface such as a conveyor belt or a drum surface, for subsequent processing.
- This process known as "melt blowing," is of particular commercial importance in the production of many products because of its ability to attenuate the fibers while they are still molten.
- any of the above processes may be used to produce bicomponent fibers for use in wicks of the present invention. It will be understood by those of ordinary skill in the art that the actual process used for a given fiber may depend on the fiber components and configuration. Regardless of the manner of forming the bicomponent fibers, they are subsequently gathered together and passed through one or more processing stations in which the fibers are bonded and formed to produce a continuous, self-sustaining, porous wick element of constant cross-section.
- the wick element may then be further treated and/or divided into individual wick elements, each wick element being a self-sustaining structure formed as a network of continuous, bonded fibers.
- This network of fibers provides a tortuous interstitial path for passage of fluids by capillary action and for interstitial entrapment of loaded substances and/or substances entrained in fluids passing therethrough.
- the process begins at S 100 and at S110, a plurality of bicomponent fibers having at least one polyamide fiber component are provided. Individual fibers are typically provided on separate bobbins from which they may be drawn through a feed roll. The fibers may alternatively be provided as a tow, or as a melt blown, spun bond, or combination non-woven roving.
- the fibers may be drawn through a temperature and humidity controlled draw box where the fibers are heated and stretched using a predetermined draw ratio.
- the predetermined draw ratio may be in a range of about 1.5 to 1 to about 6 to 1 and is preferably in a range of about 2.5 to 1 to about 3.5 to 1.
- a crimp may be established in the fibers.
- the gathered fibers Prior to crimping, the gathered fibers form a plurality of continuous, linear fiber elements. Crimping the fibers causes them to become multidimensional and has the effect of increasing the bulk and loft of the final wick product. Moreover, crimping increases the uniformity of the wick body structure and, in particular, the capillaries that make up the tortuous fluid paths through the wick product. Crimping may be accomplished by mechanical means or, with certain bicomponent fiber configurations, by inducing a self-crimping action. Mechanical crimping can be applied to any fiber type and tends to produce a zigzag or sawtooth-shaped pattern as viewed from the side and/or from above the fiber. Any suitable mechanical crimping process may be used in the practice of the present invention.
- Self-crimping fibers are generally bicomponent fibers in which the two fiber components have different shrinkage/expansion characteristics.
- one of the fiber components typically the core component in sheath-core fibers
- the self-crimping action of the fiber will be affected by the materials used in the fiber components and by the relative cross-sectional areas of the two components.
- a cross-section of a particularly preferred form of self-crimping fiber is illustrated in Figure 2 .
- the fiber 10 is a sheath-core fiber in which the cross-sections of the core component 12 and the sheath component 14 are both substantially circular (with outer radii R 1 and R 2 , respectively) but are not concentric.
- Such fibers may be referred to as eccentric sheath-core fibers.
- the eccentricity of the fiber may be defined as the ratio of the offset X between the centers of the two components and the outer radius of the fiber, which is equal to the outer radius R 1 of the sheath component.
- the degree of eccentricity and the relative cross-sectional areas of the two components may be varied to change the degree of deformation when the fibers are allowed to crimp.
- Fibers used in the wicks of the present invention typically have an eccentricity in a range from about 0.1 to about 0.5.
- the action of establishing crimps in the gathered fibers may include passing the fibers through a drawing section to stretch the fibers and then through the turbulent region of an air jet where they are allowed to relax and take on a typical self-crimped fiber pattern.
- This multi-dimensional fiber deformation results in intermingling of the gathered fibers, which is desirable in the downstream formation of a self-sustaining wick.
- the intermingled, crimped fibers are drawn through an oven or other heating device in which the temperature is at or near the melt temperature of at least one of the two fiber components.
- the oven temperature is set at or near the melt temperature of the polyamide sheath material to at least partially melt the sheath material. The environment within the oven is carefully controlled to assure even heating of the fibers.
- the intermingled fibers are drawn through a heated sizing die, which causes the intermingled, crimped fibers to make contact with one another at various spaced-apart points along the length of the melted fiber component.
- the fibers Upon cooling at S160, the fibers remain bonded at these contact points, thereby producing a self-sustaining fiber structure.
- the fibers may be allowed to cool under ambient conditions or may be cooled by passing the drawn fiber structure through a subsequent cooling die, by applying chilled air, or by applying a cooler fluid, depending on the specifics of the process.
- the fiber structure bonds are formed at various interspersed points along the polyamide sheath portions of the fibers.
- the crimped bicomponent fibers have been formed into a continuous wick body structure. Though typically rectangular, it will be understood that the cross-section of the continuous wick body may be of any geometric shape.
- the continuous wick body structure may be cut into desired lengths to form discrete wick bodies at S170.
- An exemplary final product wick 100 is represented in Figure 3 (not to scale).
- the wick 100 has a rectangular fluid transmissive wick body 110 formed from generally aligned but three dimensionally intermingled, bonded, crimped, bicomponent fibers 120. The process ends at S190.
- additive materials may include, for example, blocking agents, surfactants and reactive agents.
- Additives may be incorporated by coating or immersing the wick body structure with an additive solution before or after cutting.
- a pump may be used to apply an additive in a solution to the formed wick element.
- the amount of an additive applied to the wick may be controlled through the concentration of the additive in the solution, the pump rate and the speed of the wick through the solution.
- a stripping die may be used to remove excess additives.
- the wick structure may then be dewatered by means generally known in the art.
- the final product of the method described above is a self-sustaining network of bonded bicomponent fibers.
- This network defines a tortuous flow path for passage of fluids through the wick.
- a structure so-formed may provide a means of transporting a fluid with no flow impetus other than capillary action.
- the degree of capillary action, and thus, the flow rate for a given fluid is determined by the degree of surface energy at the boundaries of the interstitial capillaries through the fiber structure. Absent the use of enhancing additives such as surfactants, capillary surface energy will be determined by the polymer materials used in the fibers.
- the overall fluid transfer performance of the wick may also be affected by the uniformity of the intermingled fiber structure established by crimping the fibers.
- nylon fiber components in wick structures can provide relatively high fluid flow rates without the use of enhancing additives.
- the bicomponent fiber structures of the present invention at least some of the exposed fiber surfaces that form capillary boundaries are provided by the polyamide fiber component of the bicomponent fibers.
- wicks formed from sheath-core fibers with polyamide sheath components and wicks formed from side-by-side fibers having both components formed from polyamide materials all of the exposed surfaces are provided by polyamides.
- the degree of natural capillary flow potential may be determined by the relative surface area presented by the polyamide component as compared to the surface area presented by the non-polyamide component.
- the wick structures of the invention can provide a high degree of fluid flow potential. It can also be seen that, in embodiments incorporating sheath-core fiber types, the degree of flow potential is essentially independent of the volume of polyamide in the fiber sheath, as long as a sufficient fiber surface area of nylon is maintained. Accordingly, the amount of the polyamide material in the fiber may be minimized relative to a less expensive core material.
- the sheath-core fiber configuration can provide a significant advantage in that all of the exposed fiber surface may be established by a nylon sheath that forms only a fraction of the total fiber material. If surface energy were the only consideration, the wick fibers could be formed with the minimum polyamide material required for complete coverage of the core component.
- the amount and configuration of the polyamide fiber component may be related to the amount of polyamide material used. This is particularly true for sheath-core fibers having a polyamide sheath. Also, as previously discussed, the use of crimped fibers and, in particular, self-crimped fibers, affects the flow transport properties of the wick because of its effect on uniformity of the bonded fiber structure and the tortuous flow paths formed thereby.
- the crimping behavior of self-crimping fibers is generally a function, not only of the relative expansion (or contraction) behavior of the two fiber components, but also of the relative cross-sectional areas--and thus, the relative material amounts--of those components.
- the amount of polyamide material used may thus be based on multiple design constraints including parameters based on surface energy requirements, structural uniformity and bondability. However, there is also likely to be a desire to minimize the amount of polyamide material required to meet these constraints.
- the present invention provides for tailoring the fiber geometry to meet one or more of these design criteria.
- the flow surface area is essentially determined by the required fluid transfer performance.
- the remaining performance parameters may be related to the polyamide component ratio of the bicomponent fibers.
- polyamide component ratio means the ratio of the weight per unit length (or volume) of polyamide material providing a polyamide surface for the capillaries of the wick to the overall weight per unit length (or volume) of the bicomponent fiber. It can be readily seen that in bicomponent fibers having a polyamide first fiber component and a non-polyamide second fiber component, the polyamide component ratio will be the ratio of the first component weight per unit length divided by the overall fiber weight per unit length.
- a bicomponent fiber having a given polyamide sheath material and having a high polyamide component ratio may have a degree of surface energy and bondability but may also have a relatively high cost due to the high percentage of polyamide material.
- a fiber with a low polyamide component ratio may have a lower cost but may have bonding problems and may not provide a sufficient polyamide surface area.
- the polyamide component ratio may be as high as 1.0.
- the actual cross-sectional geometry of the fiber may be determined from a combination of the polyamide surface area requirements and the polyamide component ratio. If a self-crimping fiber is used, the crimping behavior may also be factored in.
- a bicomponent fiber wick of the present invention may be optimally tailored for a particular combination of wick performance properties.
- the fluid transmissive body of the bicomponent fiber wick may be formed from a plurality of bicomponent fibers bonded to each other at spaced apart contact points. As in all the wicks of the invention, the fibers collectively define tortuous three dimensional fluid flow paths through the wick body.
- the bicomponent fibers have a fiber structure comprising first and second fiber components each having discrete cross-sectional areas extending continuously along the length of the bicomponent fiber.
- the fiber includes at least one polyamide material.
- the fiber will have a first component formed from polyamide material and a second component that is not, although in some embodiments, the second component may also be a polyamide material having different properties from the polyamide of the first component.
- the bicomponent fiber geometry may be specifically adapted to provide a polyamide component ratio that provides a final wick structure adapted to meet predetermined design requirements.
- wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.10 to about 0.50. In a preferred embodiment, wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.20 to about 0.35. In a most preferred embodiment, wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.25 to about 0.30.
- Wick structures were successfully formed from bicomponent fibers having different polyamide content levels and geometries.
- the processing methods previously discussed were used to produce wicks from self-crimped sheath-core bicomponent fibers in which the core fiber component was polyethylene terephthalate (Dupont 4441) and the sheath fiber component was nylon 6 (Ultramid BASF BS403N).
- the fibers were formed using conventional bicomponent melt spinning techniques using a spin pack with 288 individual filaments. The filaments were spun to 25 dpf (denier per filament) and individual packages were creeled to provide a final wick product of sufficient density.
- the collected yarns were drawn at a 3.5 draw ratio at 150-160°C to induce a self-crimped fiber structure.
- the yarns were then passed through an oven at 200-235°C and drawn through a heated die to form a self-sustaining wick structure having a 2.45 mm by 11.5 mm rectangular cross-section.
- the continuous wick structure was then cut in 44 mm lengths.
- Two sets of wicks were produced, both having an outer fiber diameter of 38 microns.
- the wick fibers were formed with a core diameter of 29.4 microns and an eccentricity of 0.45, in order to produce a polyamide component ratio of 0.40.
- the wick fibers were formed with a core diameter of 32.9 microns and an eccentricity of 0.27, in order to produce a polyamide component ratio of 0.25.
- Both wick sets provided fully bonded self-sustaining, fluid transmissive bodies with substantially similar fluid transmission properties far in excess of conventional untreated bicomponent fiber wicks.
- the wicks of the invention have a wide applicability and may be used in any fluid transfer application. They are particularly adapted for use in assay devices such as may be used in medical applications. Thus, for example, the wicks of the present invention can be used for the transport of virtually any analyte fluid, including biological analyte fluids such as urine, blood, and saliva.
- the wicks of the invention may be used in assay devices for detecting one or more analytes including, but not limited to, hormones such as human chorionic gonadotropin (hCG) frequently used as a marker for pregnancy, antigens, enzymes, antibodies to HIV, antibodies to HTLV, antibodies to Helicobacter pylori, antibodies to hepatitis, antibodies to measles, hepatitis antigens, antibodies to terponemes, antibodies to host or infections agents, cellular markers of pathology including, but not limited to, cardiolipin, lecithin, cholesterol, lipopolysaccaride and sialic acid, antibodies to mumps, antibodies to rubella, cotinine, cocaine, benzoylecgonine, benzodizazpines, tetrahydrocannabinol, nicotine, ethanol theophylline, phenytoin, acetaminophen, lithium, diazepam, nortriptyline, secobarbital,
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Textile Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Nonwoven Fabrics (AREA)
- Multicomponent Fibers (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
- The invention relates generally to hygroscopic wicks and, more particularly, to bicomponent fiber wicks that may be adapted for transmitting analyte fluids in assay devices.
- Various assay devices are known for use in the home, office, clinic, hospital or doctor's surgery for providing an analytical result which is rapid and which requires a minimal degree of skill and involvement by the user. Examples of this are the test devices or assays for pregnancy and fertile period (ovulation). Typically in such devices the number of operations in getting the results should be minimized.
- Typical assay devices comprise a housing, a reaction medium positioned in the housing, upon which the assay chemistry occurs, and a wick for collecting the liquid to be assayed and transferring it to the reaction medium. In general, the assay device should merely require that a collection portion of the device be contacted with a sample (e.g., a urine sample for pregnancy testing), and thereafter no further user actions are required. The sample is carried from the collection portion to the reaction medium via the wick. Observation of changes to the reaction medium or a substrate carrying the reaction medium provide an analytical result. Ideally, the analytical result should be observable within a matter of minutes following sampling.
- The actual analytic techniques used to obtain the results typically determine the presence or absence of and/or quantify the amount of various analytes in tissues and fluids of organisms. Currently most diagnostic testing is done with blood, urine, fecal material, saliva, or tissue biopsy. Testing based on these materials, however, entails substantial invasion of privacy and poses a significant safety hazard (particularly with the testing of blood). Improved assay devices are required that allow for greater speed and control of the transport and analysis of the fluid sample. These devices will depend on improved wick materials and structures.
- The present invention provides wicks that make use of bicomponent fibers in which at least one of the fiber components a polyamide material. An illustrative aspect of the invention provides a bicomponent fiber wick for use in processing an analyte fluid. The bicomponent fiber wick comprises a self-sustaining, fluid transmissive body comprising a plurality of bundled, crimped, continious bicomponent fibers bonded to each other at spaced apart contact points. Each bicomponent fiber has a fiber structure comprising a first fiber component formed from a polyamide material and a second fiber component. The fibers collectively define tortuous fluid flow paths through the fluid transmissive body, the fiber structure being configured for controlling flow of the analyte fluid through the fluid transmissive body with at least a portion of the first fiber component in contact with the analyte fluid.
- The invention can be more fully understood by reading the following detailed description together with the accompanying drawing, in which like reference indicators are used to designate like elements, and in which:
-
Figure 1 is a flow diagram of a process for manufacturing a bicomponent fiber wick according to an embodiment of the invention: -
Figure 2 is a cross-sectional view of a sheath-core bicomponent fiber that may be used in embodiments of the invention; and -
Figure 3 is a nOL-to-scale perspective view of a bicomponent fiber wick according to an embodiment of the invention. - The present invention provides bicomponent fiber wicks that are particularly adapted for use in devices requiring rapid, controlled transport of fluids. They are particularly adaptable for use in assay devices requiring transport of analyte fluids. As used herein the term analyte fluid means a fluid sample that is to be analyzed for the presence of one or more analytes in the fluid sample and/or to quantify the amount of one or more analytes present in the fluid sample.
- The wicks of the present invention are formed from bicomponent fibers the structure and material constituents of which may be tailored to provide specific fluid transport properties for particular analytes and analyte fluids.
- Bicomponent fibers have been used to some extent in wicks and medical assay devices. Most prior art assay devices, however, are constructed from low cost mono-component fibers formed from such materials as low density polyethylene (LDPE), polypropylene(PP) high density polyethylene (HDPE), ultra-high molecular weight polyethylene (UHMW), polypropylene (PP), polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), polyester, and polyethersulfone (PES). It has generally been found that certain materials such as nylon 6 may be usable and, in fact may be desirable for their natural hydrophilic behavior. However, the use of nylon materials have not been favored in such mono-component applications in part due to their cost. It has also been found that non-woven hydrophilic structures formed from nylon are often not self-sustaining. Further, nylon processing often requires additional procedures to avoid inadvertent moisture absorption by the nylon fibers. In some instances, this may require a dedicated drying process. Finally, the physical and mechanical properties of spun nylon fibers are subject to changes over time (aging effects).
- The more typical, less expensive polymers such as polyolefins and polyesters that are presently used to form assay device wicks have two disadvantages: (1) They often require an additional material such as a surfactant in order to provide adequate fluid transfer performance; and (2) unless functionalized, derivatized or modified, they do not provide a reactive platform for other additives. As a result of these deficiencies, the potential use of nylon as a naturally hydrophilic wick material was investigated. The wick embodiments of the present invention make use of bicomponent fibers with natural hydrophilic properties due to the use of polyamide materials in the fiber structure. The structure of these fibers are adapted to provide an optimum polyamide material amount while maintaining the desired flow characteristics for the final wick product.
- The use of bicomponent fibers in hydrophilic structures, generally, is well known in the art. For example,
U.S. Pat. No. 5,607,766 issued Mar. 4, 1997 ,U.S. Pat. No. 5,620,641 issued Apr. 15, 1997 , andU.S. Pat. No. 5,633,082 issued May 27, 1997 disclose the manufacture and use of bicomponent fibers comprising a core of a thermoplastic material covered by a sheath of polyethylene terephthalate. These patents note that such fibers are particularly useful in the production of elongated, highly porous elements such as in the wicks used to transport bodily fluids to a test site in a diagnostic device.US-A-2002/0193030 andEP-A-0171807 are disclosing bicomponent fiber wicks having a polyamide-based component. - The wick embodiments of the present invention are self-sustaining structures formed from such fibers. The term "bicomponent" as used herein refers to the use of two polymers of different chemical nature placed in discrete cross-sectional areas of a fiber structure. The two polymers are arranged in substantially constantly positioned distinct zones across the cross-section of the bicomponent fibers that extend continuously along the length of the bicomponent fibers. While other forms of bicomponent fibers are possible, the more common bicomponent fiber types are of the "side-by-side" and "sheath-core" types. The first type is so-named because the two polymer materials literally form a side-by-side cross-sectional configuration. In "sheath-core" bicomponent fibers, a sheath of one polymer material is spun to completely cover and encompass a core of another polymer material, typically a low shrinkage, high strength thermoplastic polymeric material.
- The wick structures of the present invention may be formed from either side-by-side or sheath-core bicomponent fibers that include at least one polyamide fiber component. The polyamide fiber component may be selected from the group consisting of nylon 6, nylon 6,6, nylon 4, nylon 610, nylon 11, and
nylon 12, or copolymers of any of the various nylons with hydrophilic moieties, such as polyethylene glycol and/or poly(ethylene oxide) diamines. In some instances, both bicomponent fiber components may be polyamides selected from the group listed above. - The polymer or polymers of the second fiber component may depend on the bicomponent fiber type. In side-by-side fibers, a first fiber component may be formed from a polyamide material and a second fiber component may be formed from a material selected from a group including but not limited to polyolefins, polyesters, polyamides, polysulfones, etc. In sheath-core fibers, the sheath component may be formed from a polyamide material while the core component may be formed from a thermoplastic polymer material selected from a group including but not limited to polyamides (such as nylon 6, nylon 6,6 and other nylons) polyesters (such as polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate and polylactic acid) and polyolefins (such as syndiotactic, isotactic polypropylene and polyethylene).
- It will be noted from the above that both side-by-side and sheath-core bicomponent fiber types may have a first component of one polyamide material and a second component of a another polyamide material. Thus, wick embodiments of the invention could, for example, be formed from sheath-core fibers having a core component of nylon 6 and a sheath component of nylon 6,6.
- As will be discussed in more detail hereafter, it has been found that the fiber material content and the fiber structure of both sheath-core and side-by-side fiber types has a significant impact on certain properties of the final wick product. It has also been found that fiber material content and fiber structure may be selected to provide desired wick properties and, in fact, may be optimized based on various design criteria.
- The bicomponent fibers used in embodiments of the invention may be produced by a number of common techniques. Among such techniques are conventional melt spinning processes in which molten polymer is pumped under pressure to a spinning head and extruded from spinneret orifices into a multiplicity of continuous fibers. Melt spinning is only available for polymers having a melting point temperature less than its decomposition temperature, such as nylon, polypropylene and the like, whereby the polymer material can be melted and extruded to fiber form without decomposing. Other polymers, such as acrylics, cannot be melted without blackening and decomposing. Such polymers can be dissolved in a suitable solvent (e.g., acetate in acetone) of typically 20% polymer and 80% solvent. In a wet spinning process, the solution is pumped at room temperature through the spinneret, which is submerged in a bath of liquid (e.g., water) in which the solvent is soluble to solidify the polymeric fibers. It is also possible to dry spin the fibers into hot air, rather than a liquid bath, to evaporate the solvent and form a skin on the fiber surface. Other common spinning techniques may also be used.
- After spinning, the fibers are commonly attenuated by withdrawing them from the spinning device at a speed faster than the extrusion speed. The fibers may be attenuated by taking them up on nip rolls rotating at a speed faster than the rate of extrusion or between nip rolls operating at different speeds. Depending on the nature of the polymer, drawing the fibers in this manner can make them stronger by making them more crystalline.
- Attenuation can also be effected through the use of a melt blowing process. In this process, the fibers are attenuated by contacting them with a fluid such as high velocity air as they emanate from the spinneret orifices. The effect of the fluid is to draw the fibers into fine filaments. These filaments may be collected as an entangled web of fibers on a continuously moving surface such as a conveyor belt or a drum surface, for subsequent processing. This process, known as "melt blowing," is of particular commercial importance in the production of many products because of its ability to attenuate the fibers while they are still molten.
- Any of the above processes may be used to produce bicomponent fibers for use in wicks of the present invention. It will be understood by those of ordinary skill in the art that the actual process used for a given fiber may depend on the fiber components and configuration. Regardless of the manner of forming the bicomponent fibers, they are subsequently gathered together and passed through one or more processing stations in which the fibers are bonded and formed to produce a continuous, self-sustaining, porous wick element of constant cross-section.
- The wick element may then be further treated and/or divided into individual wick elements, each wick element being a self-sustaining structure formed as a network of continuous, bonded fibers. This network of fibers provides a tortuous interstitial path for passage of fluids by capillary action and for interstitial entrapment of loaded substances and/or substances entrained in fluids passing therethrough.
- With reference to
Figure 1 , a manufacturing process for forming bicomponent fiber wick elements according to an embodiment of the invention will now be discussed in more detail. The process begins atS 100 and at S110, a plurality of bicomponent fibers having at least one polyamide fiber component are provided. Individual fibers are typically provided on separate bobbins from which they may be drawn through a feed roll. The fibers may alternatively be provided as a tow, or as a melt blown, spun bond, or combination non-woven roving. At S120, the fibers may be drawn through a temperature and humidity controlled draw box where the fibers are heated and stretched using a predetermined draw ratio. In an illustrative embodiment, the predetermined draw ratio may be in a range of about 1.5 to 1 to about 6 to 1 and is preferably in a range of about 2.5 to 1 to about 3.5 to 1. - At S 130, a crimp may be established in the fibers. Prior to crimping, the gathered fibers form a plurality of continuous, linear fiber elements. Crimping the fibers causes them to become multidimensional and has the effect of increasing the bulk and loft of the final wick product. Moreover, crimping increases the uniformity of the wick body structure and, in particular, the capillaries that make up the tortuous fluid paths through the wick product. Crimping may be accomplished by mechanical means or, with certain bicomponent fiber configurations, by inducing a self-crimping action. Mechanical crimping can be applied to any fiber type and tends to produce a zigzag or sawtooth-shaped pattern as viewed from the side and/or from above the fiber. Any suitable mechanical crimping process may be used in the practice of the present invention.
- Self-crimping fibers are generally bicomponent fibers in which the two fiber components have different shrinkage/expansion characteristics. Usually, one of the fiber components (typically the core component in sheath-core fibers) has a higher melt temperature, lower shrinkage and higher strength than the second component. When a self-crimping fiber is heated and then allowed to relax, the difference in behavior of the two components causes the fiber to deform, or crimp, in a predictable manner. Through selection of the component materials and the cross-sectional geometry of the two fiber components, a desired three-dimensional deformation may be introduced.
- In both side-by-side and sheath-core bicomponent fibers, the self-crimping action of the fiber will be affected by the materials used in the fiber components and by the relative cross-sectional areas of the two components. A cross-section of a particularly preferred form of self-crimping fiber is illustrated in
Figure 2 . As shown, thefiber 10 is a sheath-core fiber in which the cross-sections of thecore component 12 and thesheath component 14 are both substantially circular (with outer radii R1 and R2, respectively) but are not concentric. Such fibers may be referred to as eccentric sheath-core fibers. The eccentricity of the fiber may be defined as the ratio of the offset X between the centers of the two components and the outer radius of the fiber, which is equal to the outer radius R1 of the sheath component. The degree of eccentricity and the relative cross-sectional areas of the two components may be varied to change the degree of deformation when the fibers are allowed to crimp. Fibers used in the wicks of the present invention typically have an eccentricity in a range from about 0.1 to about 0.5. - If self-crimping fibers are used in the process of
Figure 1 , the action of establishing crimps in the gathered fibers may include passing the fibers through a drawing section to stretch the fibers and then through the turbulent region of an air jet where they are allowed to relax and take on a typical self-crimped fiber pattern. This multi-dimensional fiber deformation results in intermingling of the gathered fibers, which is desirable in the downstream formation of a self-sustaining wick. - At
S 140, the intermingled, crimped fibers are drawn through an oven or other heating device in which the temperature is at or near the melt temperature of at least one of the two fiber components. In a preferred embodiment in which the fiber is a sheath-core fiber, the oven temperature is set at or near the melt temperature of the polyamide sheath material to at least partially melt the sheath material. The environment within the oven is carefully controlled to assure even heating of the fibers. AtS 150, the intermingled fibers are drawn through a heated sizing die, which causes the intermingled, crimped fibers to make contact with one another at various spaced-apart points along the length of the melted fiber component. Upon cooling at S160, the fibers remain bonded at these contact points, thereby producing a self-sustaining fiber structure. The fibers may be allowed to cool under ambient conditions or may be cooled by passing the drawn fiber structure through a subsequent cooling die, by applying chilled air, or by applying a cooler fluid, depending on the specifics of the process. In a preferred embodiment in which the fibers are sheath-core fibers, the fiber structure bonds are formed at various interspersed points along the polyamide sheath portions of the fibers. - At this point in the process, the crimped bicomponent fibers have been formed into a continuous wick body structure. Though typically rectangular, it will be understood that the cross-section of the continuous wick body may be of any geometric shape. The continuous wick body structure may be cut into desired lengths to form discrete wick bodies at S170. An exemplary
final product wick 100 is represented inFigure 3 (not to scale). Thewick 100 has a rectangular fluidtransmissive wick body 110 formed from generally aligned but three dimensionally intermingled, bonded, crimped,bicomponent fibers 120. The process ends at S190. - In some instances, it may be desirable that the final wick product be loaded or coated with an additive material. Typical additive materials may include, for example, blocking agents, surfactants and reactive agents. Additives may be incorporated by coating or immersing the wick body structure with an additive solution before or after cutting. In a particular embodiment, a pump may be used to apply an additive in a solution to the formed wick element. The amount of an additive applied to the wick may be controlled through the concentration of the additive in the solution, the pump rate and the speed of the wick through the solution. A stripping die may be used to remove excess additives. The wick structure may then be dewatered by means generally known in the art.
- Like all wick embodiments of the invention, the final product of the method described above is a self-sustaining network of bonded bicomponent fibers. This network defines a tortuous flow path for passage of fluids through the wick. As is known, a structure so-formed may provide a means of transporting a fluid with no flow impetus other than capillary action. The degree of capillary action, and thus, the flow rate for a given fluid is determined by the degree of surface energy at the boundaries of the interstitial capillaries through the fiber structure. Absent the use of enhancing additives such as surfactants, capillary surface energy will be determined by the polymer materials used in the fibers. The overall fluid transfer performance of the wick may also be affected by the uniformity of the intermingled fiber structure established by crimping the fibers.
- As previously noted, polyamide materials--and in particular, nylon--are naturally hydrophilic (i.e., have a naturally high surface energy when compared to other common fiber forming materials such as polyolefins and polyesters). Accordingly, it can be seen that the use of nylon fiber components in wick structures can provide relatively high fluid flow rates without the use of enhancing additives. In the bicomponent fiber structures of the present invention, at least some of the exposed fiber surfaces that form capillary boundaries are provided by the polyamide fiber component of the bicomponent fibers. In wicks formed from sheath-core fibers with polyamide sheath components and wicks formed from side-by-side fibers having both components formed from polyamide materials, all of the exposed surfaces are provided by polyamides. In wicks formed from side-by-side fibers in which only one fiber component is a polyamide, the degree of natural capillary flow potential may be determined by the relative surface area presented by the polyamide component as compared to the surface area presented by the non-polyamide component.
- It can thus be seen that the wick structures of the invention can provide a high degree of fluid flow potential. It can also be seen that, in embodiments incorporating sheath-core fiber types, the degree of flow potential is essentially independent of the volume of polyamide in the fiber sheath, as long as a sufficient fiber surface area of nylon is maintained. Accordingly, the amount of the polyamide material in the fiber may be minimized relative to a less expensive core material. Thus, the sheath-core fiber configuration can provide a significant advantage in that all of the exposed fiber surface may be established by a nylon sheath that forms only a fraction of the total fiber material. If surface energy were the only consideration, the wick fibers could be formed with the minimum polyamide material required for complete coverage of the core component.
- There are, however, other considerations in selecting the amount and configuration of the polyamide fiber component. For example, for a given polyamide material, the ability of the bicomponent fibers to bond to form the self-sustaining wick bodies of the invention may be related to the amount of polyamide material used. This is particularly true for sheath-core fibers having a polyamide sheath. Also, as previously discussed, the use of crimped fibers and, in particular, self-crimped fibers, affects the flow transport properties of the wick because of its effect on uniformity of the bonded fiber structure and the tortuous flow paths formed thereby. As noted above, the crimping behavior of self-crimping fibers is generally a function, not only of the relative expansion (or contraction) behavior of the two fiber components, but also of the relative cross-sectional areas--and thus, the relative material amounts--of those components.
- As a result, there may be, in some circumstances, an incentive to increase the amount of polyamide material in the bicomponent fiber beyond the minimum required to produce a particular polyamide material surface area. The amount of polyamide material used may thus be based on multiple design constraints including parameters based on surface energy requirements, structural uniformity and bondability. However, there is also likely to be a desire to minimize the amount of polyamide material required to meet these constraints. The present invention provides for tailoring the fiber geometry to meet one or more of these design criteria.
- For a given polyamide material and fiber type, the flow surface area is essentially determined by the required fluid transfer performance. The remaining performance parameters may be related to the polyamide component ratio of the bicomponent fibers. As used herein, the term "polyamide component ratio" means the ratio of the weight per unit length (or volume) of polyamide material providing a polyamide surface for the capillaries of the wick to the overall weight per unit length (or volume) of the bicomponent fiber. It can be readily seen that in bicomponent fibers having a polyamide first fiber component and a non-polyamide second fiber component, the polyamide component ratio will be the ratio of the first component weight per unit length divided by the overall fiber weight per unit length. It can also be readily seen that a bicomponent fiber having a given polyamide sheath material and having a high polyamide component ratio may have a degree of surface energy and bondability but may also have a relatively high cost due to the high percentage of polyamide material. On the other hand, a fiber with a low polyamide component ratio may have a lower cost but may have bonding problems and may not provide a sufficient polyamide surface area. It should be noted that because some bicomponent fibers may have both components formed from polyamide materials, the polyamide component ratio may be as high as 1.0.
- For a given bicomponent fiber type, the actual cross-sectional geometry of the fiber may be determined from a combination of the polyamide surface area requirements and the polyamide component ratio. If a self-crimping fiber is used, the crimping behavior may also be factored in.
- Based on the above, it can be seen that a bicomponent fiber wick of the present invention may be optimally tailored for a particular combination of wick performance properties. The fluid transmissive body of the bicomponent fiber wick may be formed from a plurality of bicomponent fibers bonded to each other at spaced apart contact points. As in all the wicks of the invention, the fibers collectively define tortuous three dimensional fluid flow paths through the wick body. The bicomponent fibers have a fiber structure comprising first and second fiber components each having discrete cross-sectional areas extending continuously along the length of the bicomponent fiber. The fiber includes at least one polyamide material. Typically, the fiber will have a first component formed from polyamide material and a second component that is not, although in some embodiments, the second component may also be a polyamide material having different properties from the polyamide of the first component. The bicomponent fiber geometry may be specifically adapted to provide a polyamide component ratio that provides a final wick structure adapted to meet predetermined design requirements.
- Although there may be some variation depending on the particular polyamide material being used, it has been determined that acceptable wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.10 to about 0.50. In a preferred embodiment, wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.20 to about 0.35. In a most preferred embodiment, wicks may be produced from crimped bicomponent fibers having a polyamide component ratio in a range of about 0.25 to about 0.30.
- Wick structures were successfully formed from bicomponent fibers having different polyamide content levels and geometries. The processing methods previously discussed were used to produce wicks from self-crimped sheath-core bicomponent fibers in which the core fiber component was polyethylene terephthalate (Dupont 4441) and the sheath fiber component was nylon 6 (Ultramid BASF BS403N). The fibers were formed using conventional bicomponent melt spinning techniques using a spin pack with 288 individual filaments. The filaments were spun to 25 dpf (denier per filament) and individual packages were creeled to provide a final wick product of sufficient density. The collected yarns were drawn at a 3.5 draw ratio at 150-160°C to induce a self-crimped fiber structure. The yarns were then passed through an oven at 200-235°C and drawn through a heated die to form a self-sustaining wick structure having a 2.45 mm by 11.5 mm rectangular cross-section. The continuous wick structure was then cut in 44 mm lengths.
- Two sets of wicks were produced, both having an outer fiber diameter of 38 microns. In the first set, the wick fibers were formed with a core diameter of 29.4 microns and an eccentricity of 0.45, in order to produce a polyamide component ratio of 0.40. In the second set, the wick fibers were formed with a core diameter of 32.9 microns and an eccentricity of 0.27, in order to produce a polyamide component ratio of 0.25. Both wick sets provided fully bonded self-sustaining, fluid transmissive bodies with substantially similar fluid transmission properties far in excess of conventional untreated bicomponent fiber wicks.
- The wicks of the invention have a wide applicability and may be used in any fluid transfer application. They are particularly adapted for use in assay devices such as may be used in medical applications. Thus, for example, the wicks of the present invention can be used for the transport of virtually any analyte fluid, including biological analyte fluids such as urine, blood, and saliva. Moreover, the wicks of the invention may be used in assay devices for detecting one or more analytes including, but not limited to, hormones such as human chorionic gonadotropin (hCG) frequently used as a marker for pregnancy, antigens, enzymes, antibodies to HIV, antibodies to HTLV, antibodies to Helicobacter pylori, antibodies to hepatitis, antibodies to measles, hepatitis antigens, antibodies to terponemes, antibodies to host or infections agents, cellular markers of pathology including, but not limited to, cardiolipin, lecithin, cholesterol, lipopolysaccaride and sialic acid, antibodies to mumps, antibodies to rubella, cotinine, cocaine, benzoylecgonine, benzodizazpines, tetrahydrocannabinol, nicotine, ethanol theophylline, phenytoin, acetaminophen, lithium, diazepam, nortriptyline, secobarbital, phenobarbital, theophylline, testosterone, estradiol, 17-hydroxyprogesterone, progesterone, thyroxine, thyroid stimulation hormone, follicle stimulating hormone, luteinizing hormone, transforming growth factor alpha, epidermal growth factor, insulin-like growth factor I and II, growth hormone release inhibiting factor, IGA and sex hormone binding globulin; and other analytes including glucose, cholesterol, caffeine, cholesterol, corticosteroid binding globulin, PSA, or DHEA binding glycoprotein.
Claims (12)
- A bicomponent fiber wick (100) for use in processing an analyte fluid, the bicomponent fiber wick comprising a self-sustaining, fluid transmissive body (110) comprising a plurality of bicomponent fibers (10, 120) bonded to each other as spaced apart contact points, each bicomponent fiber having a fiber structure comprising a first fiber component (14) formed from a polyamide material and a second fiber component (12), wherein the fibers are bundled and crimped continuous fibers, collectively defining tortuous fluid flow paths through the fluid transmissive body, the fiber structure being configured for controlling flow of the analyte fluid through the fluid transmissive body with at least a portion of the first fiber component in contact with the analyte fluid.
- A bicomponent fiber wick according to claim 1 wherein the polyamide material is selected from nylon 6, nylon 6,6, nylon 4, nylon 6,10, nylon 11, and nylon 12, and copolymers thereof.
- A bicomponent fiber wick according to claim 1 or claim 2 wherein the second fiber component (12) comprises at least one of nylon 6, nylon 6,6, polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate, polylactic acid, polypropylene and polyethylene.
- A bicomponent fiber wick according to any preceding claim wherein the bicomponent fibers are self-crimped.
- A bicomponent fiber wick according to any preceding claim wherein the fiber structure is adapted to provide a predetermined polyamide component ratio.
- A bicomponent fiber wick according to claim 5 wherein the predetermined polyamide component ratio is in a range of 0.10 to 0.50.
- A bicomponent fiber wick according to claim 6 wherein the predetermined polyamide component ratio is in a range of 0.20 to 0.35.
- A bicomponent fiber wick according to claim 7 wherein the predetermined polyamide component ratio is in a range of 0.25 to 0.30.
- A bicomponent fiber wick according to any preceding claim wherein the first fiber component (14) forms a continuous bicomponent fiber sheath along the length of the bicomponent fiber and the second fiber component (12) forms a continuous bicomponent fiber core surrounded by the sheath.
- A bicomponent fiber wick according to any preceding claim wherein the first and second fiber components each have discrete cross-sectional areas extending continuously along the length of the bicomponent fiber, the fiber structure being adapted to provide a predetermined polyamide component ratio equal to a ratio of first fiber component weight per unit volume to overall fiber weight per unit volume.
- A method of collecting an analyte fluid sample wherein the fluid sample is drawn up by means of a bicomponent fiber wick according to any preceding claim.
- A method according to claim 11 wherein the analyte fluid is one of urine, blood, serum and saliva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/006126 WO2005094245A2 (en) | 2004-03-01 | 2004-03-01 | Bicomponent fiber wick |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1781391A2 EP1781391A2 (en) | 2007-05-09 |
EP1781391A4 EP1781391A4 (en) | 2010-04-28 |
EP1781391B1 true EP1781391B1 (en) | 2012-08-15 |
Family
ID=35064230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04716122A Expired - Lifetime EP1781391B1 (en) | 2004-03-01 | 2004-03-01 | Bicomponent fiber wick |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1781391B1 (en) |
JP (1) | JP2007526477A (en) |
CN (1) | CN101208604B (en) |
CA (1) | CA2555663C (en) |
WO (1) | WO2005094245A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7888275B2 (en) | 2005-01-21 | 2011-02-15 | Filtrona Porous Technologies Corp. | Porous composite materials comprising a plurality of bonded fiber component structures |
US20160375384A1 (en) * | 2015-06-29 | 2016-12-29 | Mann+Hummel Gmbh | Filter media and methods of producing the same and uses thereof |
US11638544B2 (en) * | 2017-05-17 | 2023-05-02 | Radiometer Medical Aps | Porous optical fiber for the detection of an analyte in a fluid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ212999A (en) * | 1984-08-16 | 1987-05-29 | Chicopee | Entangled non woven fabric; fusible fibres at one surface thermobonded to base fibres |
KR940005924B1 (en) * | 1989-01-12 | 1994-06-24 | 가네보가부시끼가이샤 | Composite filament yarn and process and spinneret manufacturing the same |
EP0772484B1 (en) * | 1994-07-28 | 2008-02-27 | Pall Corporation | Fibrous web and process of preparing same |
US6303081B1 (en) * | 1998-03-30 | 2001-10-16 | Orasure Technologies, Inc. | Device for collection and assay of oral fluids |
US6419839B1 (en) * | 2000-08-15 | 2002-07-16 | Hollingsworth & Vose Company | Pool and spa filter media |
US20020193030A1 (en) * | 2001-04-20 | 2002-12-19 | Li Yao | Functional fibers and fibrous materials |
-
2004
- 2004-03-01 WO PCT/US2004/006126 patent/WO2005094245A2/en not_active Application Discontinuation
- 2004-03-01 CN CN200480042239XA patent/CN101208604B/en not_active Expired - Fee Related
- 2004-03-01 EP EP04716122A patent/EP1781391B1/en not_active Expired - Lifetime
- 2004-03-01 JP JP2007501753A patent/JP2007526477A/en active Pending
- 2004-03-01 CA CA2555663A patent/CA2555663C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1781391A4 (en) | 2010-04-28 |
CN101208604A (en) | 2008-06-25 |
CN101208604B (en) | 2012-07-11 |
JP2007526477A (en) | 2007-09-13 |
CA2555663A1 (en) | 2005-10-13 |
WO2005094245A2 (en) | 2005-10-13 |
EP1781391A2 (en) | 2007-05-09 |
CA2555663C (en) | 2010-10-26 |
WO2005094245A3 (en) | 2007-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7290668B2 (en) | Bicomponent fiber wick | |
DE69535720T2 (en) | FIBROUS TRACK AND METHOD FOR THE PRODUCTION THEREOF | |
DE69529785T2 (en) | Absorbent, polymeric nonwoven fabric with improved fluid treatment and process for making it | |
JP4272194B2 (en) | Fibrous web and method for producing the same | |
US20020193030A1 (en) | Functional fibers and fibrous materials | |
US7291300B2 (en) | Coated nanofiber webs | |
US8835709B2 (en) | Articles containing nanofibers produced from low melt flow rate polymers | |
US7888275B2 (en) | Porous composite materials comprising a plurality of bonded fiber component structures | |
JP2008533328A (en) | Multicomponent fibers having an elastomer component and bonded structures formed therefrom | |
US6642429B1 (en) | Personal care articles with reduced polymer fibers | |
DE602005005485T2 (en) | ASSAY DEVICE AND METHOD WITH CONTROLLED RIVER | |
US20040266300A1 (en) | Articles containing nanofibers produced from a low energy process | |
US20150342800A1 (en) | Hygiene Articles Containing Nanofibers | |
EA017309B1 (en) | Nonwoven fabric and process for producing the same | |
CN110359129B (en) | Preparation method of microporous skin-core structure bi-component composite fiber | |
EP1382730A1 (en) | Cosmetic cotton pad | |
EP1489929B1 (en) | Method and apparatus for applying additive to fibrous products and products produced thereby | |
EP1781391B1 (en) | Bicomponent fiber wick | |
JPH0791761B2 (en) | Wet heat adhesive non-woven fabric and method for producing the same | |
JPH01260051A (en) | Fiber web | |
KR102429602B1 (en) | heat bondable sheath-core composite fiber for hygiene, non-woven fabric containing the same, and manufacturing method thereof | |
JPH05111509A (en) | Absorptive material | |
KR20040078351A (en) | Thermally Bondable Non-circular Conjugate yarn and absorptive non-woven produced therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060811 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
R17D | Deferred search report published (corrected) |
Effective date: 20070712 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/558 20060101AFI20070807BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100329 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: FILTRONA POROUS TECHNOLOGIES CORP. |
|
17Q | First examination report despatched |
Effective date: 20110324 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602004038913 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: B01D0015080000 Ipc: B01L0003000000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B01L 3/00 20060101AFI20120213BHEP Ipc: G01N 33/52 20060101ALI20120213BHEP |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 570521 Country of ref document: AT Kind code of ref document: T Effective date: 20120815 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602004038913 Country of ref document: DE Effective date: 20121011 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20120815 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 570521 Country of ref document: AT Kind code of ref document: T Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121217 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121116 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121126 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20130516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602004038913 Country of ref document: DE Effective date: 20130516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20131129 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130402 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120815 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20040301 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130301 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20180321 Year of fee payment: 15 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190301 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220106 Year of fee payment: 19 Ref country code: DE Payment date: 20220105 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602004038913 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230301 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231003 |